Cyclosporine-induced folliculodystrophy

Journal of the American Academy of Dermatology

Volumn 50, Issue 2, 2004, Pages 310-315

  Heaphy Jr , Michael R ^a,b   Shamma, H Nicholas ^a,b   Hickmann, Martha ^a,c   White, Michael J ^a,b  

^a Wright State Univ Sch of Medicine ^*  (United States)

^b WRIGHT STATE UNIVERSITY   (United States)

^c Advanced Dermatology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE BESYLATE; BUMETANIDE; CLONIDINE; CYCLOSPORIN A; DECONAMINE SR; DESOXIMETASONE; DOXAZOSIN; FAMOTIDINE; MINOCYCLINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; PSEUDOEPHEDRINE; RETINOIC ACID; SERTRALINE; TACROLIMUS; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG WITHDRAWAL; FEMALE; FOLLICULODYSTROPHY; HISTOPATHOLOGY; HUMAN; KIDNEY GRAFT REJECTION; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SKIN DISEASE;

EID: 0842332454     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(03)00774-6     Document Type: Article

References (20)

1. Izakovic J, Buchner SA, Duggelin M, Guggenheim R, Itin PH. Hairlike hyperkeratoses in patients with kidney transplants: a new cyclosporin side-effect. Hautarzt 1995;46:841-6.
2. Chastain MA, Millikan LE, Pilomatrix dysplasia in an immunosuppressed patient. J Am Acad Dermatol 2000;43:118-22.
3. Seibel W, Sundberg JP, Lesko U, Sauk JJ, McCleary LB, Hassell TM. Cutaneous papillomatous hyperplasia in cyclosporine-A treated beagles. J Invest Dermatol 1989;93:224-30.
4. Paus R, Stenn KS, Link RE. The induction of anagen hair growth in telogen mouse skin by cyclosporine A administration. Lab Invest 1989;60:365-9.
5. Taylor M, Ashcroft ATT, Messenger AG. Cyclosporin A prolongs human hair growth in vitro. J Invest Dermatol 1993;100:237-9.
6. Wakelin SH, Emmerson RW. Excess granulation tissue development during treatment with cyclosporin. Br J Dermatol 1994;131:147-8.
7. Higgins EM, Hughes JR, Snowden S, Pembroke AC. Cyclosporin-induced periungual granulation tissue. Br J Dermatol 1995;132:829-30.
8. Lear J, Bourke JF, Burns DA. Hyperplastic pseudofolliculitis barbae associated with cyclosporin. Br J Dermatol 1997;136:132-3.
9. Adams D, Davies G. Gingival hyperplasia associated with cyclosporin A: a report of two cases. Br Dent J 1984;157:89-90.
10. Wysocki GP, Gretzinger HA, Laupacis A, Ulan RA, Stiller CR. Fibrous hyperplasia of the gingiva: a side effect of cyclosporin A therapy. Oral Surg Oral Med Oral Pathol 1983;55:274-8.
11. Ashrafi SH, Slaski K, Thu K, Neiman ES, Cunningham MP. Scanning electron microscopy of cyclosporine-induced gingival overgrowth. Scanning Microsc 1996;10:219-25.
12. Bencini PL, Montagnino G, Sala F, De Vecchi A, Crosti C, Tarantino A. Cutaneous lesions in 67 cyclosporin-treated renal transplant recipients. Dermatologica 1986;172:24-30.
13. Reznik VM, Durham BL, Jones KL, Mendoza SA. Changes in facial appearance during cyclosporin treatment. Lancet 1987;1:1405-7.
14. Busque S, Demers P, St-Louis G, Boily J-G, Tousignant J, Lemieux F, et al. Conversion from Neoral (cyclosporine) to tacrolimus of kidney transplant recipients for gingival hyperplasia or hypertrichosis. Transplant Proc 1998;30:1247-8.
15. Hancock RH, Swan RH. Nifedipine-induced gingival overgrowth. J Clin Periodontol 1992;19:12-4.
16. Frauman AG. An overview of the adverse reactions to adrenal corticosteroids. Adverse Drug React Toxicol Rev 1996;15:203-6.
17. Jiang H, Yamamoto S, Kato R. Induction of anagen in telogen mouse skin by topical application of FK506, a potent immunosuppressant. J Invest Dermatol 1995;104:523-5.
18. Yamamoto S, Jiang H, Kato R. Stimulation of hair growth by topical application of FK506, a potent immunosuppressive agent. J Invest Dermatol 1994;102;160-4.
19. Takahashi T, Kamimura A. Cyclosporin A promotes hair epithelial cell proliferation and modulates protein kinase C expression and translocation in hair epithelial cells. J Invest Dermatol 2001;117:605-11.
20. Fisher GJ, Duell EA, Nickoloff BJ, Annesley TM, Kowalke JK, Ellis CN, et al. Levels of cyclosporin in epidermis of treated psoriasis patients differentially inhibit growth of keratinocytes cultured in serum free versus serum containing media. J Invest Dermatol 1988;91:142-6.